Irene Wilson
Primary Care · Southaven, MSNPI 1477021988
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,262 and has fallen 61.6% since, to $484 in 2025. Among primary care clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $34.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$669
- GSK$439
- Novo Nordisk$428
- Abbott$307
- Bayer$293
- Boehringer Ingelheim$205
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,227100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $669 |
| GSK | 15 | $439 |
| Novo Nordisk | 14 | $428 |
| Abbott | 15 | $307 |
| Bayer | 7 | $293 |
| Boehringer Ingelheim | 11 | $205 |
| Lilly USA, LLC | 6 | $162 |
| Amarin Pharma, Inc. | 7 | $157 |
| AbbVie | 3 | $148 |
| Esperion Therapeutics, Inc. | 3 | $145 |
| Astellas Pharma US Inc | 2 | $140 |
| Amgen | 2 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Medtronic | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Mayne Pharma Commercial LLC | 1 | $96 |
| SK Life Science, Inc. | 1 | $83 |
| Urovant Sciences Inc | 1 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $81 |
| Johnson & Johnson | 1 | $60 |
| Merck | 3 | $52 |
| Currax Pharmaceuticals LLC | 4 | $49 |
| Boston Scientific | 2 | $35 |
| Shield Therapeutics Inc | 2 | $29 |
| Corcept Therapeutics | 1 | $25 |
| Exeltis, USA Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,227 in reported general payments places this provider in the 90th percentile of 80 primary care providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $19,863 |
| JardianceEmpagliflozin | 17 | $18,534 |
| MounjaroTirzepatide | 15 | $15,057 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $10,941 |
| EliquisApixaban | 13 | $8,004 |
| Atorvastatin Calcium | 141 | $1,035 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $993 |
| Azelastine Hcl | 40 | $878 |
| Pantoprazole Sodium | 63 | $732 |
| Amlodipine Besylate | 175 | $725 |
| Rosuvastatin Calcium | 80 | $685 |
| Omeprazole | 69 | $619 |
| Duloxetine Hcl | 14 | $604 |
| Esomeprazole Magnesium | 16 | $590 |
| Levothyroxine Sodium | 62 | $543 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $428 | $19,86319 claims |
| Boehringer IngelheimJardiance | $205 | $18,53417 claims |
| Lilly USA, LLCMounjaro | $162 | $15,05715 claims |
| GSKTrelegy Ellipta | $439 | $10,94111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 80 primary care providers in Mississippi.
Other primary care in Southaven
- Katrina BlackardSouthaven$14K
- Charity MilamSouthaven$3K
- Lauren BakerSouthaven$2K
- Alisha McArthur WilkesRidgeland$17K
- Sarah HarringtonTupelo$11K
- Julie HarperNewhebron$10K
- Hannah IvisonJackson$10K
- Mary EatonTupelo$4K
- Tanya SandersonTupelo$3K
- Amanda EllisKosciusko$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.